Metformin inhibits metastatic breast cancer progression and improves chemosensitivity by inducing vessel normalization via PDGF-B downregulation
Abstract Background Vascular maturity and functionality are closely associated with tumor progression and chemosensitivity. The antidiabetic agent metformin has shown its ability to inhibit tumor angiogenesis in metastatic breast cancer models. However, it remains unclear if or how metformin remodel...
Main Authors: | Ji-Chang Wang, Guang-Yue Li, Bo Wang, Su-Xia Han, Xin Sun, Yi-Na Jiang, Yan-Wei Shen, Can Zhou, Jun Feng, Shao-Ying Lu, Jian-Lin Liu, Mao-De Wang, Pei-Jun Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-06-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13046-019-1211-2 |
Similar Items
-
METTL3 increases cisplatin chemosensitivity of cervical cancer cells via downregulation of the activity of RAGE
by: Ruyi Li, et al.
Published: (2021-09-01) -
The effects of GH and PDGF on the growth and proliferation of the epithelial cells
by: M. Safari, et al.
Published: (2008-05-01) -
Autocrine Production of PDGF Stimulated by the Tenascin-C-Derived Peptide TNIIIA2 Induces Hyper-Proliferation in Glioblastoma Cells
by: Motomichi Fujita, et al.
Published: (2019-06-01) -
Gab1 mediates PDGF signaling and is essential to oligodendrocyte differentiation and CNS myelination
by: Liang Zhou, et al.
Published: (2020-01-01) -
SHP-2-Mediated Upregulation of ZEB1 Is Important for PDGF-B-Induced Cell Proliferation and Metastatic Phenotype in Triple Negative Breast Cancer
by: Lei Zhang, et al.
Published: (2020-08-01)